| abstract |
Disclosed herein are antisense compounds and methods for reducing factor 9 and increasing clotting time in individuals in need thereof. Examples of medical conditions that can be ameliorated by the administration of antisense compounds targeting Factor 9 include thrombosis, embolism, thromboembolism such as deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke . |